Mackenzie Financial’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,922
| Closed | -$275K | – | 1542 |
|
|
2022
Q3 | $275K | Sell |
4,922
-264
| -5% | -$14.8K | ﹤0.01% | 1124 |
|
|
2022
Q2 | $268K | Buy |
5,186
+1,391
| +37% | +$71.9K | ﹤0.01% | 1138 |
|
|
2022
Q1 | $276K | Buy |
3,795
+137
| +4% | +$9.96K | ﹤0.01% | 1155 |
|
|
2021
Q4 | $433K | Sell |
3,658
-1,998
| -35% | -$237K | ﹤0.01% | 1024 |
|
|
2021
Q3 | $759K | Buy |
5,656
+3,521
| +165% | +$472K | ﹤0.01% | 945 |
|
|
2021
Q2 | $346K | Buy |
+2,135
| New | +$346K | ﹤0.01% | 1036 |
|